drugset
Drugs / metoprolol xl
last change Nov 2017 re-read 9 days ago

metoprolol xl

also known as Metoprolol Succinate Extended Release · TOPROL-XL
Developed for
congestive heart failure
Investigated by
GlaxoSmithKline

Trials 1

today NCT00123903 · Ph 3
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00123903 Jul 2005 → May 2006 congestive heart failure GlaxoSmithKline Terminated No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2017-11-29 Lannett Company, Inc. Lannett Announces Agreement For Authorized Generic Version Of Toprol-XL® investorroom.com ↗

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as metoprolol xl ClinicalTrials.gov intervention name — accepted as the source's own label NCT00123903 ↗
Known as Metoprolol Succinate Extended Release “Metoprolol Succinate Extended Release (TOPROL-XL)” NCT00123903 ↗
Known as TOPROL-XL “Metoprolol Succinate Extended Release (TOPROL-XL)” NCT00123903 ↗